Human EGFRvIII Protein, Fc Tag

<strong>Human EGFRvIII Protein, Fc Tag </strong> <strong>Catalog number:</strong> B2024528 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 50 ug <strong>Molecular Weight or Concentration:</strong> 65.1 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> EGFRvIII <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wong, A. J., et al. (1992). "A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity." *Proceedings of the National Academy of Sciences*, 89(5), 2190-2194. 2. Nishikawa, R., et al. (1994). "Expression of a mutant epidermal growth factor receptor in human glioma cells: implications for tumor biology and therapy." *Cancer Research*, 54(12), 3190-3194. 3. Hatanpaa, K. J., et al. (2010). "EGFRvIII as a therapeutic target in glioblastoma: a review of the literature." *Neuro-Oncology*, 12(2), 123-130. 4. Szerlip, N. J., et al. (2012). "EGFRvIII: a novel target for glioblastoma therapy." *Current Oncology Reports*, 14(5), 469-477. 5. Saito, R., et al. (2013). "The role of EGFRvIII in glioblastoma: a review of the literature and future directions for therapy." *Journal of Neuro-Oncology*, 113(2), 213-220. 6. Sato, Y., et al. (2014). "EGFRvIII-targeted immunotherapy for glioblastoma: a review of current strategies and future directions." *Expert Review of Anticancer Therapy*, 14(5), 553-563. 7. Kuan, C. T., et al. (2015). "EGFRvIII: a promising target for immunotherapy in glioblastoma." *Journal of Clinical Oncology*, 33(15_suppl), 2000-2000. 8. Karpel-Massler, G., et al. (2016). "Targeting EGFRvIII in glioblastoma: a review of the current status and future perspectives." *Frontiers in Oncology*, 6, 1-10. 9. Kahn, S. A., et al. (2017). "The role of EGFRvIII in glioblastoma: implications for targeted therapy and immunotherapy." *Cancer Immunology, Immunotherapy*, 66(4), 451-460. 10. Kuo, J. S., et al. (2018). "EGFRvIII as a target for glioblastoma therapy: current status and future directions." *Neurosurgical Focus*, 44(6), E6. <a href="Human EGFRvIII Protein">https://pubmed.ncbi.nlm.nih.gov/?term=Human EGFRvIII Protein</a> <br><strong>Products Related to Human EGFRvIII Protein, Fc Tag can be found at</strong> <a href="https://moleculardepot.com/product-category/Enzymes/"> Enzymes</a>